Sawhney Chhavi, Subramanian Arulselvi, Kaur Manpreet, Anjum Ajaz, Albert Venencia, Soni Kapil Dev, Kumar Ajit
Department of Anaesthesia and Critical Care, JPNA Trauma Centre, All India Institute of Medical Sciences, New Delhi, India.
Saudi J Anaesth. 2013 Jan;7(1):48-56. doi: 10.4103/1658-354X.109809.
The choice of an ideal fluid administered post trauma and its subsequent influence on coagulation still poses a clinical dilemma. Hence, this study was designed to assess the influence of in vivo hemodilution with various fluid preparations (4% gelatin, 6% hydoxyethyl starch (HES), Ringer's lactate, 0.9% normal saline) on coagulation using standard coagulation parameters and real-time thromboelastography (TEG) in patients undergoing elective surgery post trauma.
In a randomized, double-blind study, 100 patients of either sex and age, belonging to ASA Grades I and II, scheduled for elective surgeries were allocated into four groups of 25 each according to the type of fluid infused. Group G (4% gelatin), Group N (0.9% normal saline), Group R (Ringer's lactate), and Group H (6% HES) received preloading with 1 L of fluid according to the group. The coagulation status of the patients was assessed during perioperative period (before surgery, after fluid preloading, and at the end of the surgery) using both conventional coagulation analysis and TEG.
Analysis of variance (ANOVA), post hoc and Pearson Chi-square test were used.
In all the patients preloaded with gelatin, there was a significant increase in prothrombin time index (PTI; 14.88±0.90 vs. 13.78±3.01, P<0.001) and international normalized ratio (INR; 1.12±0.09 vs. 1.09±0.19, P<0.05) compared to the baseline value. An increase was observed in these parameters in the postoperative period also. In the HES group, there was statistically significant increase in PT time (15.70±1.51 vs. 13.74±0.75, P=0.01) and INR (1.20±0.15 vs. 1.03±0.17, P<0.001) as compared to the baseline. In the intergroup comparisons, the patients preloaded with HES had a significant increase in INR (1.20±0.15 vs. 1.12±0.09, P=0.04) and reaction time (R time; 6.84±2.55 min vs. 4.79±1.77 min, P=0.02) as compared to the gelatin group. The fall in coagulation time (k time; 2.16±0.98 vs. 3.94±2.6, P=0.02), rise in maximum amplitude (MA; 61.94±14.08 vs. 50.11±14.10, P=0.04), and rise in A20 (56.17±14.66 vs. 43.11±14.24, P=0.05) were more in patients preloaded with RL as compared to the HES group. 100% patients in the gelatin group, 84.2% patients in the NS group, 94.4% patients in the RL group, and 66.7% patients in the HES group had hypocoagulable (R time > 14 min) state in the postoperative period.
Crystalloids are optimal volume expanders in trauma, with RL having beneficial effects on coagulation system (decrease in k time and increase in MA and A20). Among the colloids, HES 6% (130/0.4) affects coagulation parameters (increase in PTI, INR, R time, k time) more than gelatin. Trial registration (protocol number-IEC/NP-189/2011).
创伤后理想补液的选择及其对凝血的后续影响仍是一个临床难题。因此,本研究旨在通过标准凝血参数和实时血栓弹力图(TEG),评估不同液体制剂(4%明胶、6%羟乙基淀粉(HES)、乳酸林格氏液、0.9%生理盐水)进行体内血液稀释对创伤后择期手术患者凝血功能的影响。
在一项随机、双盲研究中,将100例年龄、性别不限,美国麻醉医师协会(ASA)分级为I级和II级,计划进行择期手术的患者,根据输注液体的类型分为四组,每组25例。G组(4%明胶)、N组(0.9%生理盐水)、R组(乳酸林格氏液)和H组(6% HES)分别根据分组预先输注1L液体。在围手术期(手术前、液体预负荷后和手术结束时),使用传统凝血分析和TEG评估患者的凝血状态。
采用方差分析(ANOVA)、事后检验和Pearson卡方检验。
与基线值相比,所有预先输注明胶的患者凝血酶原时间指数(PTI;14.88±0.90 vs. 13.78±3.01,P<0.001)和国际标准化比值(INR;1.12±0.09 vs. 1.09±0.19,P<0.05)均显著升高。术后这些参数也有所升高。与基线相比,HES组PT时间(15.70±1.51 vs. 13.74±0.75,P=0.01)和INR(1.20±0.15 vs. 1.03±0.17,P<0.001)有统计学显著升高。组间比较中,与明胶组相比,预先输注HES的患者INR(1.20±0.15 vs. 1.12±0.09,P=0.04)和反应时间(R时间;6.84±2.55分钟 vs. 4.79±1.77分钟,P=0.02)显著升高。与HES组相比,预先输注乳酸林格氏液的患者凝血时间(k时间;2.16±0.98 vs. 3.94±2.6,P=0.02)下降、最大振幅(MA;61.94±14.08 vs. 50.11±14.10,P=0.04)升高以及A20升高(56.17±14.66 vs. 43.11±14.24,P=0.05)更为明显。术后,明胶组100%的患者、生理盐水组84.2%的患者、乳酸林格氏液组94.4%的患者和HES组66.7%的患者处于低凝状态(R时间>14分钟)。
晶体液是创伤时最佳的容量扩充剂,乳酸林格氏液对凝血系统有有益影响(k时间缩短、MA和A20升高)。在胶体液中,6% HES(130/0.4)比明胶对凝血参数的影响更大(PTI、INR、R时间、k时间升高)。试验注册(方案编号-IEC/NP-189/2011)。